Matthew R. Ritter
Corporate Officer/Principal at EQUILLIUM, INC.
Profile
Matthew R.
Ritter is currently working as the Senior Vice President-Corporate Development at Equillium, Inc. He previously worked as a Principal at Lonza, Inc. and as a Manager-Research & Development at EyeCyte, Inc. Dr. Ritter completed his undergraduate degree at the University of California, Irvine and obtained a doctorate degree from the Keck School of Medicine of USC.
Matthew R. Ritter active positions
| Companies | Position | Start |
|---|---|---|
| EQUILLIUM, INC. | Corporate Officer/Principal | - |
Former positions of Matthew R. Ritter
| Companies | Position | End |
|---|---|---|
Lonza, Inc.
 Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Corporate Officer/Principal | - |
EyeCyte, Inc.
 EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Matthew R. Ritter
| University of California, Irvine | Undergraduate Degree |
| Keck School of Medicine of USC | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EQUILLIUM, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Lonza, Inc. provides chemical ingredient products. The company is headquartered in Allendale, NJ. | Process Industries |
EyeCyte, Inc.
EyeCyte, Inc. Pharmaceuticals: MajorHealth Technology EyeCyte, Inc. develops products for the treatment of retinal disease. It focuses on treatments for age-related macular degeneration (AMD) and diabetic retinopathy. The company was founded by Mohammad El-Kalay and Martin Friedlander in 2008 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Matthew R. Ritter